A lot of people remember the first time they saw eye floaters. It usually happens at random. You could be looking at the sky, ...

Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the best low priced biotech stocks to invest in. Ocular Therapeutix Inc.

This case report describes a woman in her 60s diagnosed with primary vitreoretinal lymphoma (PVRL) with leptomeningeal ...

You glance up at a blue sky and notice something dark drifting across your view. Or maybe there’s a fixed, shadowy patch that ...

New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI's unmatched durability in wet AMD with sustained disease control AXPAXLI demonstrated robust CSFT control with a median time of 39 weeks ...

New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI's unmatched durability in wet AMD with sustained disease control AXPAXLI demonstrated robust CSFT control with a median time of 39 weeks ...

Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.

FDA approves Eylea HD for extended 20-week dosing in patients with wet age-related macular degeneration and diabetic macular edema.

Even the world’s brightest and bravest are titillated by turd. Astronauts mentally and physically prepare for any obstacle that can come their way while soaring through space — including funneling ...

The VFFQ-23 may be superior to the VFQ-25 for identifying patients who may benefit from surgical intervention for vitreous floaters. For patient’s with vitreous floaters, a questionnaire correlates ...

In primary care settings, new‑onset vitreous floaters strongly predict retinal detachment (RD), a risk that increases with the additional presence of flashes, and increases significantly when both ...